focus -WSS

focus

author：entertainment 2025-09-28 02:47:31 - browse：7783

Five people put coins in a box containing coins and cash on stage — coverage from STAT — Adobe

In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social network into a financial safety net to cover the cost of expensive treatments or long illnesses. Millions of Americans have started crowdfunding campaigns for medical bills, and tens of millions have donated to them, mostly through the undisputed sector leader, GoFundMe.

Nora Kenworthy, a nursing and health studies professor at the University of Washington, Bothell, has spent years studying the world of crowdfunding for health care — along with the way it ends up amplifying the inequities that already dictate who goes into medical debt.

In her new book, “Crowded Out: The True Costs of Crowdfunding Healthcare,” which will be released on Tuesday, she looks at what she calls the “toxicities” that drive medical crowdfunding campaigns. STAT spoke with Kenworthy about those issues, as well as the difficult moral decisions potential donors face when deciding whether to contribute. The following interview is condensed and edited for clarity.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： After gene therapy, two congenitally deaf children hear for the first time

WSS

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Study: Adult vaccinations pay for themselves in societal benefits

How to improve immunocompromised access to mAb treatments

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Study: AI not yet building 'n

NIH chief: government has fallen behind pharma on clinical trials

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Alkermes shareholders re

Medicare’s new pay boost for primary care is angering specialists

Malaria cases in Florida and Texas: Here’s what you need to know

Readout LOUD podcast: What to know about H5N1 bird flu

Activists slam private health insurers over coverage restrictions

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Researchers on aging grapple with how to calculate biological age

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Study suggests Covid rebound is far more common with Paxlovid than without

Wikipedia

Medicare says breakthrough device reimbursement rule to come by summer

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Study suggests Covid rebound is far more common with Paxlovid than without

Bird flu outbreak in cows is latest avian flu curveball

Healthy food access boosts outcomes in two studies

Ohio still needs to do more to protect the right to abortion

focus

leisure time

entertainment

entertainment